# A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies

> **NCT01567384** · PHASE1 · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Cancer
- Neoplasms
- Tumors

## Interventions

- **DRUG:** OSI-906 and Pemetrexed

## Key facts

- **NCT ID:** NCT01567384
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-05
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The sponsor withdrew support for the study before any patients were enrolled.
- **Last updated:** 2013-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01567384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01567384, "A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01567384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*